Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus

NCT07885176 is registered in ClinicalTrials.gov with University of Regensburg as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07885176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus
Lead sponsor
University of Regensburg
Phase
Not applicable
Overall status
Recruiting
Start date
September 19, 2026
Completion date
August 31, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tinnitus, tinnitus, bilateral

Arms

As registered; 3 arms.

  • H1-coil ExperimentalDeepTms

    18 Hz, 2000 pulses

  • H4-coil ExperimentalDeepTms

    1 Hz, 2000 pulses

  • H7-coil Sham comparatorDeepTms

    18 Hz, 2000 pulses placebo

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Changes in Tinnitus Burden 12 weeks: from enrollment to the end of treatment after two weeks, plus Follow Up after 10 weeks

    Changes in Tinnitus Burden Measured Using the Tinnitus Handicap Inventory (THI) from Baseline to the End of Treatment, Including Group Comparisons.

    The THI consists of 25 items designed to evaluate the perceived impact of tinnitus on an individual's daily life. Each item provides three response options: 'No', 'Sometimes' and 'Yes', which are scored as 0, 2 and 4 points respectively. The total THI score is obtained by summing the scores of all items, resulting in a score that ranges from 0 to 100, with higher scores indicating greater perceived handicap due to tinnitus.

Lead sponsor's other trials

University of Regensburg, most recent start first.

Similar trials

Same condition (Tinnitus) and phase, most recent start first.